Not applicableUnknownNCT02090322
What this trial is testing
Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1
Who this might be right for
Retinopathy of Prematurity
Universidad Autonoma de San Luis Potosí 60